The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

PAREXEL International Corp

Nasdaq: PRXL
Last

(U.S.) $67.49

Today's change+0.27 +0.40%
Updated April 24 4:00 PM EDT. Delayed by at least 15 minutes.
 

PAREXEL International Corp

Nasdaq: PRXL
Last

(U.S.) $67.49

Today's change+0.27 +0.40%
Updated April 24 4:00 PM EDT. Delayed by at least 15 minutes.

PAREXEL International Corp up (U.S.)$0.27

PAREXEL International Corp closed up Friday by (U.S.)$0.27 or 0.40% to (U.S.)$67.49. Shares have lost 1.69% over the last five days, but have gained 21.47% over the last year to date. This security has outperformed the S&P 500 by 24.17% during the last year.

Key company metrics

  • Open(U.S.) $67.24
  • Previous close(U.S.) $67.22
  • High(U.S.) $67.54
  • Low(U.S.) $66.32
  • Bid / Ask-- / --
  • YTD % change+21.47%
  • Volume402,185
  • Average volume (10-day)395,544
  • Average volume (1-month)384,020
  • Average volume (3-month)436,404
  • 52-week range(U.S.) $41.79 to (U.S.) $71.42
  • Beta1.04
  • Trailing P/E25.36×
  • P/E 1 year forward24.43×
  • Forward PEG1.39×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.66
Updated April 24 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.52%

Based on its net profit margin of 6.52%, PAREXEL International Corp is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue575574585578
Total other revenue--------
Total revenue575574585578
Gross profit169174185171
Total cost of revenue406400400407
Total operating expense522520526526
Selling / general / administrative999910397
Research & development--------
Depreciation / amortization20202121
Interest expense (income), net operating--------
Unusual expense (income)----00
Other operating expenses, total--------
Operating income53545952
Interest income (expense), net non-operating-2-2-2-3
Gain (loss) on sale of assets--------
Other--------
Income before tax54555650
Income after tax39374035
Income tax, total15181615
Net income39374035
Total adjustments to net income--------
Net income before extra. items39374035
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items39374035
Inc. avail. to common incl. extra. items39374035
Diluted net income39374035
Dilution adjustment------0
Diluted weighted average shares56565758
Diluted EPS excluding extraordinary itemsvalue per share0.700.670.700.60
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.700.670.690.60